INTESTINAL DECARBOXYLATION OF L-DOPA IN RELATION TO DOSE REQUIREMENT IN PARKINSONS-DISEASE

被引:24
作者
GRANERUS, AK
JAGENBURG, R
SVANBORG, A
机构
[1] UNIV GOTHENBURG, VASA HOSP, DEPT GERIATRICS 2, GOTHENBURG, SWEDEN
[2] SAHLGRENS HOSP, DEPT CLIN CHEM, SF-41345 GOTHENBURG, SWEDEN
关键词
D O I
10.1007/BF00506633
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:429 / 439
页数:11
相关论文
共 12 条
[11]   DOPA AND 3-O-METHYLDOPA IN CEREBROSPINAL FLUID OF PARKINSONISM PATIENTS DURING TREATMENT WITH ORAL L-DOPA [J].
SHARPLES.NS ;
MCCANN, DS .
CLINICA CHIMICA ACTA, 1971, 31 (01) :155-&
[12]   DRUG-INDUCED CHANGES OF EXTRACEREBRAL DOPA METABOLISM IN MAN [J].
TISSOT, R ;
BARTHOLINI, G ;
PLETSCHER, A .
ARCHIVES OF NEUROLOGY, 1969, 20 (02) :187-+